PETER COFFMAN: Open Payments
NPI 1174559439 · SAINT MARYS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,175 in 45 payments from 12 companies in 2025. Trend: 2023 $10,083 · 2024 $5,698 · 2025 $4,175
Speaker / faculty: $2,700Food & beverage: $1,475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $2,776 |
| Alkermes, Inc. | 8 | $368 |
| Otsuka America Pharmaceutical, Inc. | 6 | $222 |
| E.R. Squibb & Sons, L.L.C. | 6 | $214 |
| Janssen Pharmaceuticals, Inc | 8 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Axsome Therapeutics, Inc. | 4 | $109 |
| Teva Pharmaceuticals USA, Inc. | 1 | $94 |
| Neurocrine BioSciences, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
Products named: VRAYLAR, LYBALVI, COBENFY, ARISTADA, ABILIFY MAINTENA, CAPLYTA, Auvelity, SPRAVATO.
Industry payments across PA — which companies pay providers there.
